Sanuwave Health Stock Receives ‘Buy’ Rating from Roth Capital Research
Roth Capital has initiated comprehensive research coverage on Sanuwave Health (NASDAQ:SNWV), marking a significant development for the shock wave technology company. In a report released on Tuesday…
Cantor Fitzgerald Reiterates ‘Overweight’ Rating for BridgeBio Pharma (BBIO)
BridgeBio Pharma (NASDAQ:BBIO) has once again captured the attention of the investment community, with Cantor Fitzgerald reaffirming its “overweight” rating, signaling strong confidence in the biotechnology firm’s…